Imperial College London
Alternate

Jiri Pavlu

Faculty of Medicine, Department of Immunology and Inflammation

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

+44 (0)20 3313 8117j.pavlu Website

 
 
//

Location

 

Leuka Building R2.20Hammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Monsalvo:2016,
author = {Monsalvo, S and Sevillano, B and Innes, AJ and Lasa, M and Skinner, L and Stumpfle, R and Altaf, S and Yebra, E and Macdonald, D and Milojkovic, D and Chaidos, A and Gabriel, I and Brett, S and Broomhead, R and Patel, P and Waheed, U and Pavlu, J and Palanicawandar, R and Kanfer, E and Szydlo, R and Apperley, J and Olavarria, E},
pages = {5987--5987},
publisher = {American Society of Hematology},
title = {The Intensive Care Trial for Critically Ill Onco-Haematologic Patients: The Need for Response Criteria at 5 Days of Full Treatment to Separate Good Risk Patients and Avoid Futile Intensive Care Interventions},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Monsalvo,S
AU  - Sevillano,B
AU  - Innes,AJ
AU  - Lasa,M
AU  - Skinner,L
AU  - Stumpfle,R
AU  - Altaf,S
AU  - Yebra,E
AU  - Macdonald,D
AU  - Milojkovic,D
AU  - Chaidos,A
AU  - Gabriel,I
AU  - Brett,S
AU  - Broomhead,R
AU  - Patel,P
AU  - Waheed,U
AU  - Pavlu,J
AU  - Palanicawandar,R
AU  - Kanfer,E
AU  - Szydlo,R
AU  - Apperley,J
AU  - Olavarria,E
EP  - 5987
PB  - American Society of Hematology
PY  - 2016///
SN  - 0006-4971
SP  - 5987
TI  - The Intensive Care Trial for Critically Ill Onco-Haematologic Patients: The Need for Response Criteria at 5 Days of Full Treatment to Separate Good Risk Patients and Avoid Futile Intensive Care Interventions
ER  -
Download